Wired The latest dominant Covid variants have stronger infectiousness than their predecessors and the ability to evade vaccine-induced antibodies. The northern hemisphere is entering yet another Covid wave—while much of the world acts as if the pandemic were over, cases are surging again. The US Centers for Disease Control and Prevention (CDC) has recorded an uptick in positive Covid tests, emergency department visits, hospitalizations, and deaths in recent weeks, while cases and hospital admissions in the UK are creeping up too. But it’s in Japan where the surge is particularly visible. The country’s National Institute of Infectious Diseases has reported that the average number of infected people per medical institution has been increasing rapidly since June. In particular, Okinawa prefecture has witnessed the highest number of newly hospitalized patients since reporting began, and it’s possible that the virus is spreading in Japan at a rate that exceeds the country’s last two big waves, in September 2023 and January 2024.
The culprits behind the surge are a new set of variants: KP.3, LB.1, and KP.2.3. Descendants of the Omicron sublineage JN.1 that gained dominance over Christmas, they’ve become the driver of new infections around the world, with KP.3 seemingly gaining dominance. As of July 15, the US CDC estimated approximately 37 percent of new Covid cases in the United States were due to KP.3, with KP.2 accounting for 24 percent and LB.1 15 percent. KP.3 has been rising rapidly over the past few months: As of May 11, it accounted for an estimated 9 percent of cases in the US; a month later on June 11, its share was 25 percent.
Together, these viruses are referred to as the FLiRT variants, because they all have a mutation in the spike protein that changes its 456th amino acid from phenylalanine (F) to leucine (L) and its 346th amino acid from arginine (R) to threonine (T). According to a paper by the Institute of Medical Science at the University of Tokyo, published earlier this year in the journal The Lancet Infectious Diseases, these variants are more transmissible than earlier mainstream variants and have a high ability to evade neutralizing antibodies.